James J McGarrigle
Overview
Explore the profile of James J McGarrigle including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
571
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang Y, Qi M, McGarrigle J, Xing Y, Mendoza-Elias J, Bochenek M, et al.
Pancreas
. 2020 May;
49(5):706-713.
PMID: 32433410
Objectives: Previously, we showed that diazoxide (DZ), an effective ischemic preconditioning agent, protected rodent pancreas against ischemia-reperfusion injury. Here, we further investigate whether DZ supplementation to University of Wisconsin (UW)...
2.
Xie X, Doloff J, Yesilyurt V, Sadraei A, McGarrigle J, Omami M, et al.
Nat Biomed Eng
. 2019 Apr;
2(12):894-906.
PMID: 30931173
Continuous glucose monitors (CGMs), used by patients with diabetes mellitus, can autonomously track fluctuations in blood glucose over time. However, the signal produced by CGMs during the initial recording period...
3.
Bochenek M, Veiseh O, Vegas A, McGarrigle J, Qi M, Marchese E, et al.
Nat Biomed Eng
. 2019 Mar;
2(11):810-821.
PMID: 30873298
The transplantation of pancreatic islet cells could restore glycaemic control in patients with type-I diabetes. Microspheres for islet encapsulation have enabled long-term glycaemic control in diabetic rodent models; yet human...
4.
Kronekova Z, Pelach M, Mazancova P, Uhelska L, Trelova D, Razga F, et al.
Sci Rep
. 2018 Jan;
8(1):1637.
PMID: 29374272
A next-generation cure for type 1 diabetes relies on immunoprotection of insulin-producing cells, which can be achieved by their encapsulation in microspheres made of non-covalently crosslinked hydrogels. Treatment success is...
5.
Omami M, McGarrigle J, Reedy M, Isa D, Ghani S, Marchese E, et al.
Curr Diab Rep
. 2017 May;
17(7):47.
PMID: 28523592
Purpose Of Review: Type 1 diabetes mellitus (T1DM) is an autoimmune disease that results from the destruction of insulin-producing pancreatic β cells in the islets of Langerhans. Islet cell transplantation...
6.
Xing Y, Nourmohammadzadeh M, Elias J, Chan M, Chen Z, McGarrigle J, et al.
Biomed Microdevices
. 2016 Aug;
18(5):80.
PMID: 27534648
We present a novel pumpless microfluidic array driven by surface tension for studying the physiology of pancreatic islets of Langerhans. Efficient fluid flow in the array is achieved by surface...
7.
Yeh C, Wang L, McGarrigle J, Wang Y, Liao C, Omami M, et al.
Cell Transplant
. 2016 Aug;
26(1):33-44.
PMID: 27524672
This study investigates manufacturing procedures that affect islet isolation outcomes from donor pancreata standardized by the North American Islet Donor Score (NAIDS). Islet isolations performed at the University of Illinois,...
8.
Vegas A, Veiseh O, Gurtler M, Millman J, Pagliuca F, Bader A, et al.
Nat Med
. 2016 Apr;
22(4):446.
PMID: 27050590
No abstract available.
9.
Nourmohammadzadeh M, Xing Y, Lee J, Bochenek M, Mendoza-Elias J, McGarrigle J, et al.
Lab Chip
. 2016 Mar;
16(8):1466-72.
PMID: 26999734
In this study, we present a microfluidic array for high-resolution imaging of individual pancreatic islets. The device is based on hydrodynamic trapping principle and enables real-time analysis of islet cellular...
10.
Vegas A, Veiseh O, Gurtler M, Millman J, Pagliuca F, Bader A, et al.
Nat Med
. 2016 Jan;
22(3):306-11.
PMID: 26808346
The transplantation of glucose-responsive, insulin-producing cells offers the potential for restoring glycemic control in individuals with diabetes. Pancreas transplantation and the infusion of cadaveric islets are currently implemented clinically, but...